Although medications such as SSRI antidepressants and clomipramine are approved for treating symptoms of obsessive compulsive disorder, these treatments are far from effective for many patients who have this diagnosis. At this time there are no other options for the several patients who do not respond to approved treatment.

Researchers have recently begun to examine if better treatments can be developed for patients that have difficult to treat obsessive compulsive disorder. Specifically, there is evidence that targeting the glutamate system may lead to improved control of OCD symptoms. Thus, the Northwest Clinical Research Center is part of a clinical trial being conducted to evaluate this question. This research cannot take place without the help of volunteers.

Study Medication

All research participants will continue taking prescribed medication for obsessive compulsive disorder. The study medication will be given in addition to standard treatment for OCD.

How We Can Help
Fill in your contact information above or call our office at (425) 453-0404 to speak with one of our clinical staff to set up your evaluation appointment. Study participants will receive the following at No Cost:

    Medical Evaluation
    Investigational Drug
    Study Related Medical Care
    Complimentary Transportation or Travel Stipend
    Compensation up to $900